The Northern Ireland Market
Northern Ireland's Pharmaceuticals & Life Sciences market operates under UK regulatory frameworks with unique post-Brexit complexity — the Windsor Framework creates distinct arrangements for Northern Ireland that affect data flows, regulatory alignment, and the compliance position of organizations serving both Northern Ireland and Republic of Ireland markets simultaneously.
Pharmaceuticals & Life Sciences organizations in Northern Ireland navigate UK GDPR and the Windsor Framework's data governance implications while managing cross-border data flows to the Republic that have EU GDPR implications. Engineering teams serving this market need both frameworks built into the architecture — not addressed as an afterthought when cross-border data flows are discovered.
Compliance Coverage
Every system we deploy for Pharmaceuticals & Life Sciences in Northern Ireland is FDA 21 CFR Part 11-compliant from architecture through deployment. FDA 21 CFR Part 11 and HIPAA compliance is enforced automatically at every commit — not assessed after the fact.
Engagement Scope
Duration: 8–16 weeks
A focused team deployed against a single Pharmaceuticals & Life Sciences platform in Northern Ireland. FDA 21 CFR Part 11 and HIPAA-compliant architecture from day one. Fixed price, fixed output, no discovery phase.
Duration: 3–9 months
40–100 engineers running parallel workstreams across a Pharmaceuticals & Life Sciences transformation in Northern Ireland. Multi-system compliance governance and FDA 21 CFR Part 11 and HIPAA certification maintained across the full program.
Duration: 6–18 months
100–250+ engineers owning the complete technology infrastructure for a Pharmaceuticals & Life Sciences organization in Northern Ireland. Full FDA 21 CFR Part 11 and HIPAA compliance across every system, every integration, every deployment.